{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:48:13Z","timestamp":1788266893513,"version":"build-2803163510"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3,1]]},"DOI":"10.1093\/hmg\/ddu542","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T06:06:19Z","timestamp":1414649179000},"page":"1322-1335","source":"Crossref","is-referenced-by-count":41,"title":["Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease"],"prefix":"10.1093","volume":"24","author":[{"given":"William M.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Siedlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy A.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Wilson-Delfosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Mieyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu G.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,10,29]]},"reference":[{"key":"key\n\t\t\t\t20170503080428_DDU542C1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(02)00058-7","article-title":"Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells","volume":"321","author":"Bai","year":"2002","journal-title":"Neurosci. Lett."},{"key":"key\n\t\t\t\t20170503080428_DDU542C2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1523\/JNEUROSCI.4589-10.2011","article-title":"Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade","volume":"31","author":"Hu","year":"2011","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170503080428_DDU542C3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neulet.2007.12.068","article-title":"Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+","volume":"433","author":"De Simoni","year":"2008","journal-title":"Neurosci. Lett."},{"key":"key\n\t\t\t\t20170503080428_DDU542C4","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/bi9018658","article-title":"Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson's disease","volume":"49","author":"Sabens","year":"2010","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170503080428_DDU542C5","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3390\/nu4101399","article-title":"Dysregulation of glutathione homeostasis in neurodegenerative diseases","volume":"4","author":"Johnson","year":"2012","journal-title":"Nutrients"},{"key":"key\n\t\t\t\t20170503080428_DDU542C6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/exnr.1993.1008","article-title":"Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection","volume":"119","author":"Filloux","year":"1993","journal-title":"Exp. Neurol."},{"key":"key\n\t\t\t\t20170503080428_DDU542C7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jnr.10663","article-title":"Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells","volume":"73","author":"Gomez-Santos","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"key\n\t\t\t\t20170503080428_DDU542C8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainres.2013.05.036","article-title":"Reynosin protects against neuronal toxicity in dopamine-induced SH-SY5Y cells and 6-hydroxydopamine-lesioned rats as models of Parkinson's disease: reciprocal up-regulation of E6-AP and down-regulation of alpha-synuclein","volume":"1524","author":"Ham","year":"2013","journal-title":"Brain Res."},{"key":"key\n\t\t\t\t20170503080428_DDU542C9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mds.25249","article-title":"The genetics of Parkinson's disease: progress and therapeutic implications","volume":"28","author":"Singleton","year":"2013","journal-title":"Mov. Disord."},{"key":"key\n\t\t\t\t20170503080428_DDU542C10","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/jnr.21949","article-title":"Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease","volume":"87","author":"Gandhi","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"key\n\t\t\t\t20170503080428_DDU542C11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"Alpha-synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"key\n\t\t\t\t20170503080428_DDU542C12","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/hmg\/dds003","article-title":"LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1","volume":"21","author":"Wang","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170503080428_DDU542C13","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1523\/JNEUROSCI.5311-12.2013","article-title":"Calcium entry and alpha-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons","volume":"33","author":"Dryanovski","year":"2013","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170503080428_DDU542C14","doi-asserted-by":"crossref","first-page":"11144","DOI":"10.1021\/bi800966v","article-title":"Kinetic and mechanistic characterization and versatile catalytic properties of mammalian glutaredoxin 2: implications for intracellular roles","volume":"47","author":"Gallogly","year":"2008","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170503080428_DDU542C15","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1089\/ars.2008.2089","article-title":"Molecular mechanisms and clinical implications of reversible protein S-glutathionylation","volume":"10","author":"Mieyal","year":"2008","journal-title":"Antioxid. Redox Signal."},{"key":"key\n\t\t\t\t20170503080428_DDU542C16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1089\/ars.2005.7.348","article-title":"Glutaredoxin: role in reversible protein S-glutathionylation and regulation of redox signal transduction and protein translocation","volume":"7","author":"Shelton","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"key\n\t\t\t\t20170503080428_DDU542C17","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1089\/ars.2011.4474","article-title":"Glutaredoxin 1 protects dopaminergic cells by increased protein glutathionylation in experimental Parkinson's disease","volume":"17","author":"Rodriguez-Rocha","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"key\n\t\t\t\t20170503080428_DDU542C18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1096\/fj.02-0771fje","article-title":"Glutaredoxin is essential for maintenance of brain mitochondrial complex I: studies with MPTP","volume":"17","author":"Kenchappa","year":"2003","journal-title":"FASEB J."},{"key":"key\n\t\t\t\t20170503080428_DDU542C19","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1096\/fj.03-1075fje","article-title":"Estrogen and neuroprotection: higher constitutive expression of glutaredoxin in female mice offers protection against MPTP-mediated neurodegeneration","volume":"18","author":"Kenchappa","year":"2004","journal-title":"FASEB J."},{"key":"key\n\t\t\t\t20170503080428_DDU542C20","doi-asserted-by":"crossref","first-page":"12045","DOI":"10.1073\/pnas.90.24.12045","article-title":"apl-1, a Caenorhabditis elegans gene encoding a protein related to the human beta-amyloid protein precursor","volume":"90","author":"Daigle","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170503080428_DDU542C21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.expneurol.2013.09.024","article-title":"Modeling neurodegenerative diseases in Caenorhabditis elegans","volume":"250","author":"Li","year":"2013","journal-title":"Exp. Neurol."},{"key":"key\n\t\t\t\t20170503080428_DDU542C22","doi-asserted-by":"crossref","first-page":"23103","DOI":"10.3390\/ijms141123103","article-title":"Oxidative stress mechanisms underlying Parkinson's disease-associated neurodegeneration in C. elegans","volume":"14","author":"Chakraborty","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"key\n\t\t\t\t20170503080428_DDU542C23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nbd.2010.04.002","article-title":"LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease","volume":"40","author":"Yao","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"key\n\t\t\t\t20170503080428_DDU542C24","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1523\/JNEUROSCI.5157-04.2005","article-title":"Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans","volume":"25","author":"Cao","year":"2005","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170503080428_DDU542C25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1471-4159.2003.01809.x","article-title":"Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein","volume":"86","author":"Lakso","year":"2003","journal-title":"J. Neurochem."},{"key":"key\n\t\t\t\t20170503080428_DDU542C26","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170503080428_DDU542C27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/bies.200900163","article-title":"Mechanisms in dominant parkinsonism: the toxic triangle of LRRK2, alpha-synuclein, and tau","volume":"32","author":"Taymans","year":"2010","journal-title":"Bioessays"},{"key":"key\n\t\t\t\t20170503080428_DDU542C28","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0896-6273(00)81199-X","article-title":"C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway","volume":"26","author":"Sawin","year":"2000","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170503080428_DDU542C29","first-page":"ii","article-title":"Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes","volume":"835","author":"Berkowitz","year":"2008","journal-title":"J. Vis. Exp."},{"key":"key\n\t\t\t\t20170503080428_DDU542C30","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1089\/ars.2008.2291","article-title":"Mechanistic and kinetic details of catalysis of thiol-disulfide exchange by glutaredoxins and potential mechanisms of regulation","volume":"11","author":"Gallogly","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"key\n\t\t\t\t20170503080428_DDU542C31","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1096\/fj.12-226852","article-title":"Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson's disease therapies","volume":"27","author":"Bisaglia","year":"2013","journal-title":"FASEB J."},{"key":"key\n\t\t\t\t20170503080428_DDU542C32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.phrs.2011.01.004","article-title":"Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism","volume":"63","author":"Liu","year":"2011","journal-title":"Pharmacol. Res."},{"key":"key\n\t\t\t\t20170503080428_DDU542C33","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/jnr.21191","article-title":"Oxidative damage in nucleic acids and Parkinson's disease","volume":"85","author":"Nakabeppu","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"key\n\t\t\t\t20170503080428_DDU542C34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0304-3940(82)90390-1","article-title":"Parkinson's disease: a disorder due to nigral glutathione deficiency?","volume":"33","author":"Perry","year":"1982","journal-title":"Neurosci. Lett."},{"key":"key\n\t\t\t\t20170503080428_DDU542C35","doi-asserted-by":"crossref","first-page":"e50683","DOI":"10.1371\/journal.pone.0050683","article-title":"Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cells","volume":"7","author":"Lopert","year":"2012","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170503080428_DDU542C36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/ars.2009.2832","article-title":"DJ-1 loss by glutaredoxin but not glutathione depletion triggers Daxx translocation and cell death","volume":"13","author":"Saeed","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"key\n\t\t\t\t20170503080428_DDU542C37","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1093\/hmg\/ddu026","article-title":"Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila","volume":"23","author":"Angeles","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170503080428_DDU542C38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1089\/ars.2006.1513","article-title":"Does thioredoxin-1 prevent mitochondria- and endoplasmic reticulum-mediated neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine?","volume":"9","author":"Bai","year":"2007","journal-title":"Antioxid. Redox Signal."},{"issue":"Suppl. 11","key":"key\n\t\t\t\t20170503080428_DDU542C39","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/mds.20457","article-title":"Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy","volume":"20","author":"Olanow","year":"2005","journal-title":"Mov. Disord."},{"key":"key\n\t\t\t\t20170503080428_DDU542C40","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuropharm.2013.11.026","article-title":"Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2\/ARE signaling pathway","volume":"79","author":"Lou","year":"2014","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t20170503080428_DDU542C41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.pharmthera.2013.12.007","article-title":"Antioxidant gene therapy against neuronal cell death","volume":"142","author":"Navarro-Yepes","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"key\n\t\t\t\t20170503080428_DDU542C42","doi-asserted-by":"crossref","first-page":"e62166","DOI":"10.1371\/journal.pone.0062166","article-title":"An ultra high-throughput, whole-animal screen for small molecule modulators of a specific genetic pathway in Caenorhabditis elegans","volume":"8","author":"Leung","year":"2013","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170503080428_DDU542C43","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/hmg\/dds431","article-title":"Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity","volume":"22","author":"Yao","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170503080428_DDU542C44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1326-1-17","article-title":"LRRK2 in Parkinson's disease and dementia with Lewy bodies","volume":"1","author":"Zhu","year":"2006","journal-title":"Mol. Neurodegener."},{"key":"key\n\t\t\t\t20170503080428_DDU542C45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0014-5793(95)01066-N","article-title":"Cloning, expression and characterization of human thioltransferase (glutaredoxin) in E. coli","volume":"374","author":"Chrestensen","year":"1995","journal-title":"FEBS Lett."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/24\/5\/1322\/14143813\/ddu542.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T20:30:18Z","timestamp":1565987418000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddu542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,29]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,10,29]]},"published-print":{"date-parts":[[2015,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddu542","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10,29]]}}}